Imaging has become an important adjunct to the clinical assessment of uterine cancer, specially magnetic resonance imaging (MRI) studies. In cervical cancer, the two areas in which MRI is superior to other diagnostic imaging modalities are local diseases staging and evaluation for local recurrence. MRI is an integral part in staging the primary tumour, monitoring responce to treatment, detecting complications and recurrence, and in planning radiotheraphy. MRI has a crucial role in the development of fertility-sparing surgery in young women with cervical cancer. Imaging continually evolves in response to changes in clinical practice and technologic improvements. The choice of imaging modality is not only case specific but also depends of the radiologic experience and equipment availability.